Embolization of the Middle Meningeal Artery
Embolization of the Middle Meningeal Artery is a medical procedure with 6 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
3
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Management of CSDH With or Without EMMA- a Randomized Control Trial
Embolization of Middle Meningeal Artery for Subdural Hematoma in Canada (EMMA Can)
Puerto Rico Embolization of the Middle Meningeal Artery for the Treatment of Chronic Subdural Hematoma Trial (PREMMA)
Embolization of Middle Meningeal Artery in Chronic Subdural Hematoma
Endovascular vs Conservative Treatment in Patients With Chronic Subdural Hematomas and Mild Symptoms
Clinical Trials (6)
Management of CSDH With or Without EMMA- a Randomized Control Trial
Embolization of Middle Meningeal Artery for Subdural Hematoma in Canada (EMMA Can)
Puerto Rico Embolization of the Middle Meningeal Artery for the Treatment of Chronic Subdural Hematoma Trial (PREMMA)
Embolization of Middle Meningeal Artery in Chronic Subdural Hematoma
Endovascular vs Conservative Treatment in Patients With Chronic Subdural Hematomas and Mild Symptoms
Dartmouth Middle Meningeal Embolization Trial (DaMMET)
All 6 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 6